ArticleCancer biology & therapy2015

Interleukin-4 receptor-targeted liposomal doxorubicin as a model for enhancing cellular uptake and antitumor efficacy in murine colorectal cancer.

Chih-Yung Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.